Results 11 to 20 of about 37,507 (250)
Journal of the American College of Cardiology, 2010 Intense investigation continues on the pathobiology of stent thrombosis (ST) because of its morbidity and mortality. Because little advance has been made in outcomes following ST, ongoing research is focused on further understanding predictive factors as well as ST frequency and timing in various patient subsets, depending upon whether a drug-eluting ...
Holmes, DR +8 more
openaire +6 more sources
Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study. [PDF]
PLoS ONE, 2014 The widespread use of coronary stents has exposed a growing population to the risk of stent thrombosis, but the importance in terms of risk of ST-segment elevation myocardial infarctions (STEMIs) remains unclear.We studied five years follow-up data for 2,
Søren Lund Kristensen +12 more
doaj +1 more source
Coronary Stent Thrombosis in COVID-19 Patients: A Systematic Review of Cases Reported Worldwide
Viruses, 2022 Approximately 5 million percutaneous coronary interventions are performed worldwide annually. Therefore, stent-related complications pose a serious public health concern.
Wojciech Jan Skorupski +3 more
doaj +1 more source
Stent thrombosis and drug-eluting stents [PDF]
Journal of Cardiology, 2011 Coronary stents have been used for the treatment of patients with coronary artery disease (CAD), and significantly improved procedural safety and are associated with a lower rate of restenosis compared with balloon angioplasty alone. Drug-eluting stents (DES) have been dominant for the treatment of CAD with efficacy in significantly reducing both ...
Takafumi Hiro +2 more
openaire +3 more sources
Stent thrombosis revisited [PDF]
European Heart Journal, 1996 The choice of antithrombotic regimes after stent implantation has increased. Complication rates have improved and in-hospital stay is reduced with the less aggressive regimes. For de novo stenting in large vessels with a good result, ticlopidine plus aspirin or even aspirin alone appears attractive.
A. H. Gershlick, R. K. Aggarwal
openaire +3 more sources
Medicine Science, 2020 The purpose of this study was to investigate whether biochemical parameters on admission can predict the development of acute stent thrombosis within 24 hours of presentation in patients with ST-segment elevation myocardial infarction (STEMI) who ...
Yusuf Cekici
doaj +1 more source
Mitigation of the Turbulence within an Arteriovenous Fistula with a Stent Implantation [PDF]
Physical Review Fluids, 7 (2022), 2022 The transitional flow which initiates within the junction (anastomosis) of an arteriovenous fistula (AVF) is known to be a contributing factor in the onset of vascular disease. A novel treatment method involving the implantation of a flexible stent across the anastomosis has enabled the retention of a large proportion of functioning AVFs, despite the ...
arxiv +1 more source
Subacute Stent Thrombosis in Intracranial Stenting [PDF]
Stroke, 2009 Background and Purpose— We sought to determine the safety of intracranial stenting with respect to subacute stent thrombosis in patients being treated with standardized antiplatelet therapy. Methods— We retrospectively ...
C. Riedel +4 more
openaire +3 more sources
Drug-eluting stent thrombosis [PDF]
Therapeutic Advances in Cardiovascular Disease, 2009 Stent thrombosis is a rare complication following stent implantation; if it occurs, however, it is associated with a high morbidity and mortality. Despite reduced rates of restenosis, drug-eluting stents (DES) have not reduced the incidence of stent thrombosis as compared with bare-metal stents (BMS).
Stähli, B E, Camici, G G, Tanner, F C
openaire +3 more sources
Heart Views, 2011 Very late stent thrombosis occurs more frequently with drug-eluting stents and tends to occur despite dual antiplatelet therapy or after long periods of clopidogrel discontinuation.
Prashanth Panduranga +1 more
doaj +1 more source